Keyphrases
COVID-19
100%
BNT162b2
100%
Omicron Variant
100%
Hospitalization
80%
Confidence Interval
60%
Vaccination
50%
Vaccine Effectiveness
50%
Life Support
20%
Two-dose
20%
Predominant Period
20%
Disease Prevention
10%
Centers for Disease Control
10%
Illness
10%
Unvaccinated
10%
Immune Evasion
10%
Control Test
10%
Critical Illness
10%
Duration of Protection
10%
Laboratory Confirmation
10%
Test-negative Design
10%
Messenger RNA Vaccine
10%
Full Vaccination
10%
BNT162b2 Vaccine
10%
Medicine and Dentistry
COVID-19
100%
Omicron Coronavirus Variant
100%
Diseases
22%
Critical Illness
11%
Immune Evasion
11%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
RNA Vaccine
11%
Messenger RNA
11%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
100%
Coronavirinae
81%
Critical Illness
9%
SARS Coronavirus
9%
RNA Vaccine
9%
Messenger RNA
9%
Biochemistry, Genetics and Molecular Biology
Coronavirinae
100%
Immune Evasion
11%
SARS Coronavirus
11%
Messenger RNA
11%